GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Net Margin %

Immunoclin (Immunoclin) Net Margin % : -122,340.00% (As of Oct. 2014)


View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Immunoclin's Net Income for the three months ended in Oct. 2014 was $-6.12 Mil. Immunoclin's Revenue for the three months ended in Oct. 2014 was $0.01 Mil. Therefore, Immunoclin's net margin for the quarter that ended in Oct. 2014 was -122,340.00%.

The historical rank and industry rank for Immunoclin's Net Margin % or its related term are showing as below:


IMCL's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.37
* Ranked among companies with meaningful Net Margin % only.

Immunoclin Net Margin % Historical Data

The historical data trend for Immunoclin's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Net Margin % Chart

Immunoclin Annual Data
Trend Feb12 Jan13 Jan14
Net Margin %
- -37.16 -

Immunoclin Quarterly Data
May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Apr14 Jul14 Oct14
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -122,340.00

Competitive Comparison of Immunoclin's Net Margin %

For the Biotechnology subindustry, Immunoclin's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunoclin's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunoclin's Net Margin % distribution charts can be found below:

* The bar in red indicates where Immunoclin's Net Margin % falls into.



Immunoclin Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Immunoclin's Net Margin for the fiscal year that ended in Jan. 2014 is calculated as

Net Margin=Net Income (A: Jan. 2014 )/Revenue (A: Jan. 2014 )
=-12.98/0
= %

Immunoclin's Net Margin for the quarter that ended in Oct. 2014 is calculated as

Net Margin=Net Income (Q: Oct. 2014 )/Revenue (Q: Oct. 2014 )
=-6.117/0.005
=-122,340.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Immunoclin  (GREY:IMCL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Immunoclin Net Margin % Related Terms

Thank you for viewing the detailed overview of Immunoclin's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Immunoclin (Immunoclin) Business Description

Traded in Other Exchanges
N/A
Address
9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210
Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines